Overview
- 2 public-safe observations are available for this inspection.
- 2 structured CFR citations are represented.
- 1 investigator is tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
20 Mar 2026
21 CFR 812.100
Investigator non-compliance with agreement/plan/regulations
Cited by Theressa B Smith
20 Mar 2026
21 CFR 812.140(a)(3)(ii)
Investigator records of relevant observations inadequate
Cited by Theressa B Smith
Inspected site
RKRishi K. Wadhwa, M.D.Shreveport, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 812.100 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 812.140(a)(3)(ii) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 2 observations
The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere